NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma

Takumi Kobayashi, Brianna L. Doff, Rory C. Rearden, Graham R. Leggatt, Stephen R. Mattarollo*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma'. Together they form a unique fingerprint.

Immunology and Microbiology